Company Profile for Salmedix Inc.Business Editors --(BUSINESS WIRE) Salmedix, an oncopharmaceutical company, in-licenses, develops and will commercialize new drugs, with an initial focus on hematologic hematological, hematologic pertaining to or emanating from blood cells. hematological tests total and differential white cell counts, hematocrit estimation, erythrocyte count. cancers. The Company has exclusively licensed its initial product portfolio and intellectual property, invented in the laboratories of its scientific founders, from the University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States). . This portfolio includes two clinical-stage compounds, SDX-101, a component of a drug which is currently marketed for non-oncology indications, and SDX-102, described above, plus multiple earlier-stage product candidates. All of these agents function by selectively targeting metabolic met·a·bol·ic adj. Of, relating to, or resulting from metabolism. Metabolic Refers to the chemical processes of an organ or organism. differences between cancer cells cells once believed to be peculiar to cancers, but now know to be epithelial cells differing in no respect from those found elsewhere in the body, and distinguished only by peculiarity of location and grouping. See also: Cancer and normal cells. An experienced team of "drug hunters" continues to identify and plans to in-license additional clinical-stage oncology oncology /on·col·o·gy/ (ong-kol´ah-je) the sum of knowledge regarding tumors; the study of tumors. on·col·o·gy n. agents.
Company: Salmedix Inc.
Headquarters Address: 9380 Judicial Drive
San Diego, CA 92121
Main Telephone: 858-622-5050
Website: www.salmedix.com
Type of Organization: Private
Industry: Health: Biotechnology
Key Executives: CEO: David Kabakoff
CFO: Anita Busquets
CFO
Contact: Anita Busquets
Phone: 858-622-5050
Email: abusquets@salmedix.com
CEO
Contact: David Kabakoff
Phone: 858-622-5050
Email: dkabakoff@salmedix.com
|
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion